Generation Bio Co. (GBIO)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Collaboration revenue | 765 | 8,723 | 7,554 | 4,091 |
| Research and development | 15,499 | 15,357 | 15,088 | 16,388 |
| General and administrative | 7,668 | 8,834 | 9,181 | 9,515 |
| Loss on lease termination | -514 | -1,138 | -1,169 | -1,497 |
| Total operating expenses | 23,681 | 25,329 | 25,438 | 27,400 |
| Loss from operations | -22,916 | -16,606 | -17,884 | -23,309 |
| Other income and interest income, net | 1,993 | 1,804 | - | - |
| Nonoperating income (expense) | - | - | 2,571 | 2,877 |
| Net loss | -20,923 | -14,802 | -15,313 | -20,432 |
| Unrealized losses on marketable securities | -81 | -74 | 599 | -83 |
| Comprehensive loss | -21,004 | -14,876 | -14,714 | -20,515 |
| Earnings per share, basic | -3.12 | -0.22 | -0.23 | -0.31 |
| Earnings per share, diluted | -3.12 | -0.22 | -0.23 | -0.31 |
| Weighted average number of shares outstanding, basic | 6,703,586 | 67,002,511 | 66,738,468 | 66,531,000 |
| Weighted average number of shares outstanding, diluted | 6,703,586 | 67,002,511 | 66,738,468 | 66,531,000 |